Longeveron Inc.
LGVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001721484
No open-market purchases or sales by Longeveron Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $3.35M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Longeveron Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 12 | 13 | +1 |
| Shares | 363.8K | 302.3K | −61.5K (−16.9%) |
| Value | $2.96M | $1.07M | −$1.89M (−63.9%) |
New holders (5)
Institutions that held Longeveron Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| TownSquare Capital, LLC | 14,450 | $51.0K | 0.00% |
| TAP Consulting, LLC | 10,000 | $35.0K | 0.01% |
| Total Clarity Wealth Management, Inc. | 1,000 | $4.00K | 0.00% |
| The PNC Financial Services Group, Inc. | 227 | $1.00K | 0.00% |
| Morgan Stanley | 200 | $1.00K | 0.00% |
Sold out (4)
Institutions that held Longeveron Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pura Vida Investments, LLC | 67,120 | $546.0K |
| Two Sigma Advisers, LP | 52,100 | $424.0K |
| Renaissance Technologies LLC | 38,200 | $311.0K |
| Royal Bank of Canada | 3,500 | $28.0K |